@techcrunch.com 1 year ago
Nanopath is looking to drastically change medical diagnostics
@xconomy.com 5 years ago
Celsee Charts Expansion Plans as Single-Cell Analysis Demand Grows
@xconomy.com 5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?